Comparing Foley Catheter Balloon With Early Amniotomy for Induction of Labor at Term
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03629548 |
|
Recruitment Status :
Completed
First Posted : August 14, 2018
Last Update Posted : February 4, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Induced Vaginal Delivery | Procedure: early amniotomy Device: foley catheter balloon placement | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 250 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Comparing Combined Foley Catheter Balloon and PGE2 Vaginal Ovule With Early Amniotomy and PGE2 for Induction of Labor at Term: A Randomized Study |
| Actual Study Start Date : | August 15, 2018 |
| Actual Primary Completion Date : | September 15, 2019 |
| Actual Study Completion Date : | October 1, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: early amniotomy plus dinoprostone
10 mg dinoprostone vaginal ovul will be inserted to the posterior fornix. Early amniotomy will be done in the early active phase of labor for early amniotomy group ( half of participants) when the cervix will be dilated 3 cm using the amniotomy hook.
|
Procedure: early amniotomy
10 mg PGE2 vaginal ovul will be inserted to the posterior fornix. Early amniotomy will be done in the early active phase of labor for early amniotomy group ( half of participants) when the cervix will be dilated 3 cm using the amniotomy hook. |
|
Experimental: foley balloon catheter plus dinoprostone
an 18-F Foley catheter which filling with 30 mL of saline solution will be placed into the cervix and after placement of balloon catheter 10 mg dinoprostone vaginal ovul will be inserted to the posterior fornix
|
Device: foley catheter balloon placement
an 18-F Foley catheter which filling with 30 mL of saline solution will be placed into the cervix and after placement of balloon catheter 10 mg PGE2 vaginal ovul will be inserted to the posterior fornix
Other Name: mechanic and medical method |
- induction-to- delivery time [ Time Frame: from the beginning of induction until the labor ]the length of time between the beginning of induction and the end of labor
- induction-to-active phase of labor time [ Time Frame: from the beginning of induction until the labor ]the length of time between the beginning of induction and the onset of labor
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | term pregnancies |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- singleton pregnancy,
- gestational age ≥37 weeks,
- intact membranes,
- cephalic presentation,
- bishop score ≤5,
- had obstetrical indications for induction of labor,
- had less than three uterine contractions in every 10 minutes.
Exclusion Criteria:
- Patients who had contraindications for vaginal delivery,
- previous uterine surgery,
- fetal malpresentation,
- multifetal pregnancy,
- more than three contractions in 10 minutes,
- contraindications to prostaglandins,
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03629548
| Turkey | |
| Zeynep Kamil Education and Research Hospital | |
| Istanbul, Uskudar, Turkey, 34668 | |
| Study Director: | ahmet eser, M.D. | Zeynep Kamil Maternity and Children's Training and Research Hospital, Department of Obstetrics and Gynecology, Istanbul, Turkey |
| Responsible Party: | Ahmet Eser, Principal investigator, Zeynep Kamil Maternity and Pediatric Research and Training Hospital |
| ClinicalTrials.gov Identifier: | NCT03629548 |
| Other Study ID Numbers: |
48 |
| First Posted: | August 14, 2018 Key Record Dates |
| Last Update Posted: | February 4, 2021 |
| Last Verified: | February 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
| Product Manufactured in and Exported from the U.S.: | No |
|
dinoprostone early amniotomy labor induction foley bulb |

